vs
Side-by-side financial comparison of R F INDUSTRIES LTD (RFIL) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $22.7M, roughly 1.2× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -147.1%, a 147.9% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -67.6%).
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
RFIL vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.7M | $28.1M |
| Net Profit | $173.0K | $-41.3M |
| Gross Margin | 36.8% | — |
| Operating Margin | 4.0% | -147.6% |
| Net Margin | 0.8% | -147.1% |
| Revenue YoY | 22.9% | -67.6% |
| Net Profit YoY | 172.7% | -182.8% |
| EPS (diluted) | $0.01 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.7M | $28.1M | ||
| Q3 25 | $19.8M | $32.5M | ||
| Q2 25 | $18.9M | $15.7M | ||
| Q1 25 | $19.2M | $8.0M | ||
| Q4 24 | $18.5M | $86.6M | ||
| Q3 24 | $16.8M | $2.1M | ||
| Q2 24 | $16.1M | $500.0K | ||
| Q1 24 | $13.5M | $0 |
| Q4 25 | $173.0K | $-41.3M | ||
| Q3 25 | $392.0K | $-51.2M | ||
| Q2 25 | $-245.0K | $-44.9M | ||
| Q1 25 | $-245.0K | $-33.9M | ||
| Q4 24 | $-238.0K | $49.9M | ||
| Q3 24 | $-705.0K | $-19.1M | ||
| Q2 24 | $-4.3M | $-12.5M | ||
| Q1 24 | $-1.4M | $-10.3M |
| Q4 25 | 36.8% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 29.8% | — | ||
| Q4 24 | 31.3% | — | ||
| Q3 24 | 29.5% | — | ||
| Q2 24 | 29.9% | — | ||
| Q1 24 | 24.5% | — |
| Q4 25 | 4.0% | -147.6% | ||
| Q3 25 | 3.6% | -163.7% | ||
| Q2 25 | 0.6% | -302.9% | ||
| Q1 25 | 0.3% | -466.3% | ||
| Q4 24 | 0.5% | 54.5% | ||
| Q3 24 | -2.5% | -1051.6% | ||
| Q2 24 | -2.6% | -3068.0% | ||
| Q1 24 | -15.5% | — |
| Q4 25 | 0.8% | -147.1% | ||
| Q3 25 | 2.0% | -157.4% | ||
| Q2 25 | -1.3% | -285.6% | ||
| Q1 25 | -1.3% | -425.7% | ||
| Q4 24 | -1.3% | 57.7% | ||
| Q3 24 | -4.2% | -925.0% | ||
| Q2 24 | -26.7% | -2503.2% | ||
| Q1 24 | -10.1% | — |
| Q4 25 | $0.01 | $-0.41 | ||
| Q3 25 | $0.04 | $-0.52 | ||
| Q2 25 | $-0.02 | $-0.46 | ||
| Q1 25 | $-0.02 | $-0.35 | ||
| Q4 24 | $-0.02 | $0.52 | ||
| Q3 24 | $-0.07 | $-0.20 | ||
| Q2 24 | $-0.41 | $-0.13 | ||
| Q1 24 | $-0.13 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $35.2M | $114.3M |
| Total Assets | $73.0M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $245.0M | ||
| Q3 25 | $3.0M | $288.2M | ||
| Q2 25 | $3.6M | $240.1M | ||
| Q1 25 | $1.3M | $275.7M | ||
| Q4 24 | $839.0K | $314.0M | ||
| Q3 24 | $1.8M | $204.6M | ||
| Q2 24 | $1.4M | $218.7M | ||
| Q1 24 | $4.5M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $35.2M | $114.3M | ||
| Q3 25 | $34.8M | $147.7M | ||
| Q2 25 | $34.2M | $192.3M | ||
| Q1 25 | $34.2M | $229.0M | ||
| Q4 24 | $34.1M | $256.8M | ||
| Q3 24 | $34.1M | $201.0M | ||
| Q2 24 | $34.6M | $215.2M | ||
| Q1 24 | $38.7M | $223.9M |
| Q4 25 | $73.0M | $327.7M | ||
| Q3 25 | $73.2M | $372.8M | ||
| Q2 25 | $72.7M | $313.5M | ||
| Q1 25 | $70.4M | $327.3M | ||
| Q4 24 | $71.0M | $351.2M | ||
| Q3 24 | $71.9M | $217.6M | ||
| Q2 24 | $72.8M | $222.0M | ||
| Q1 24 | $79.1M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.1M | $-43.5M |
| Free Cash FlowOCF − Capex | $2.0M | — |
| FCF MarginFCF / Revenue | 9.0% | — |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 12.13× | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.1M | $-43.5M | ||
| Q3 25 | $-311.0K | $-47.0M | ||
| Q2 25 | $2.2M | $-39.6M | ||
| Q1 25 | $601.0K | $-40.7M | ||
| Q4 24 | $-244.0K | $42.0M | ||
| Q3 24 | $2.4M | $-14.5M | ||
| Q2 24 | $197.0K | $-7.3M | ||
| Q1 24 | $840.0K | $-6.7M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-419.0K | $-47.2M | ||
| Q2 25 | $2.2M | $-39.6M | ||
| Q1 25 | $574.0K | $-40.8M | ||
| Q4 24 | $-418.0K | $41.7M | ||
| Q3 24 | $2.1M | $-14.6M | ||
| Q2 24 | $28.0K | $-7.3M | ||
| Q1 24 | $697.0K | $-6.8M |
| Q4 25 | 9.0% | — | ||
| Q3 25 | -2.1% | -145.4% | ||
| Q2 25 | 11.4% | -252.2% | ||
| Q1 25 | 3.0% | -512.1% | ||
| Q4 24 | -2.3% | 48.2% | ||
| Q3 24 | 12.6% | -706.3% | ||
| Q2 24 | 0.2% | -1463.4% | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.1% | 1.1% | ||
| Q4 24 | 0.9% | 0.3% | ||
| Q3 24 | 1.5% | 6.8% | ||
| Q2 24 | 1.0% | 7.6% | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
